Artículos de revistas sobre el tema "Inhibition covalente"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Inhibition covalente".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Aljoundi, Aimen, Ahmed El Rashedy, Patrick Appiah-Kubi y Mahmoud E. S. Soliman. "Coupling of HSP72 α-Helix Subdomains by the Unexpected Irreversible Targeting of Lysine-56 over Cysteine-17; Coevolution of Covalent Bonding". Molecules 25, n.º 18 (16 de septiembre de 2020): 4239. http://dx.doi.org/10.3390/molecules25184239.
Texto completoLiu, S. Q. y P. A. Knauf. "Lys-430, site of irreversible inhibition of band 3 Cl- flux by eosin-5-maleimide, is not at the transport site". American Journal of Physiology-Cell Physiology 264, n.º 5 (1 de mayo de 1993): C1155—C1164. http://dx.doi.org/10.1152/ajpcell.1993.264.5.c1155.
Texto completoYang, Jianhong, Yong Li, Wei Yan, Weimin Li, Qiang Qiu, Haoyu Ye y Lijuan Chen. "Covalent modification of Cys-239 in β-tubulin by small molecules as a strategy to promote tubulin heterodimer degradation". Journal of Biological Chemistry 294, n.º 20 (2 de abril de 2019): 8161–70. http://dx.doi.org/10.1074/jbc.ra118.006325.
Texto completoMaksimenko, A. V. y R. Sh Beabealashvili. "Theoretical Grounding and Formation of Experimental Approaches to Hyaluronidase Structure Consolidation due to Its Computational Interactions with Shortchain Glycosaminoglycan Ligands". Биоорганическая химия 49, n.º 4 (1 de julio de 2023): 369–83. http://dx.doi.org/10.31857/s0132342323020161.
Texto completoBhatia, Sumeena, Steven C. Almo, Stanley G. Nathenson y Richard J. Hodes. "Dynamic equilibrium of B7-1 dimers and monomers is important for regulation of TCR/CD28 – mediated T cell activation (33.28)". Journal of Immunology 182, n.º 1_Supplement (1 de abril de 2009): 33.28. http://dx.doi.org/10.4049/jimmunol.182.supp.33.28.
Texto completoKuznetsova, Anastasiya, Philipp Klein y Till Opatz. "Halogenated 2,1,3-benzoxadiazoles as Potential Fluorescent Warheads for Covalent Protease Inhibitors". Proceedings 9, n.º 1 (14 de noviembre de 2018): 54. http://dx.doi.org/10.3390/ecsoc-22-05670.
Texto completoHognon, Cécilia, Marco Marazzi y Cristina García-Iriepa. "Atomistic-Level Description of the Covalent Inhibition of SARS-CoV-2 Papain-like Protease". International Journal of Molecular Sciences 23, n.º 10 (23 de mayo de 2022): 5855. http://dx.doi.org/10.3390/ijms23105855.
Texto completoBisconte, Angelina, Ronald Hill, Michael Bradshaw, Erik Verner, David Finkle, Ken Brameld, Jens Funk, David Goldstein y Phil Nunn. "Efficacy in collagen induced arthritis models with a selective, reversible covalent Bruton’s tyrosine kinase inhibitor PRN473 is driven by durable target occupancy rather than extended plasma exposure (THER5P.904)". Journal of Immunology 194, n.º 1_Supplement (1 de mayo de 2015): 139.6. http://dx.doi.org/10.4049/jimmunol.194.supp.139.6.
Texto completoBeck, Philipp, Christian Dubiella y Michael Groll. "Covalent and non-covalent reversible proteasome inhibition". Biological Chemistry 393, n.º 10 (1 de octubre de 2012): 1101–20. http://dx.doi.org/10.1515/hsz-2012-0212.
Texto completoPiestrzeniewicz, Mariola K., Dorota Wilmańska, Janusz Szemraj, Kazimierz Studzian y Marek Gniazdowski. "Interactions of Novel Morpholine and Hexamethylene Derivatives of Anthracycline Antibiotics with DNA". Zeitschrift für Naturforschung C 59, n.º 9-10 (1 de octubre de 2004): 739–48. http://dx.doi.org/10.1515/znc-2004-9-1020.
Texto completoMüller, Patrick, Mergim Meta, Jan Laurenz Meidner, Marvin Schwickert, Jessica Meyr, Kevin Schwickert, Christian Kersten et al. "Investigation of the Compatibility between Warheads and Peptidomimetic Sequences of Protease Inhibitors—A Comprehensive Reactivity and Selectivity Study". International Journal of Molecular Sciences 24, n.º 8 (13 de abril de 2023): 7226. http://dx.doi.org/10.3390/ijms24087226.
Texto completoGerling, Katharina, Sabrina Ölschläger, Meltem Avci-Adali, Bernd Neumann, Ernst Schweizer, Christian Schlensak, Hans-Peter Wendel y Sandra Stoppelkamp. "A Novel C1-Esterase Inhibitor Oxygenator Coating Prevents FXII Activation in Human Blood". Biomolecules 10, n.º 7 (13 de julio de 2020): 1042. http://dx.doi.org/10.3390/biom10071042.
Texto completoStellmacher, Lena, Tatyana Sandalova, Sarah Schneider, Gunter Schneider, Georg A. Sprenger y Anne K. Samland. "Novel mode of inhibition byD-tagatose 6-phosphate through a Heyns rearrangement in the active site of transaldolase B variants". Acta Crystallographica Section D Structural Biology 72, n.º 4 (24 de marzo de 2016): 467–76. http://dx.doi.org/10.1107/s2059798316001170.
Texto completoBetori, Rick C., Yue Liu, Rama K. Mishra, Scott B. Cohen, Stephen J. Kron y Karl A. Scheidt. "Targeted Covalent Inhibition of Telomerase". ACS Chemical Biology 15, n.º 3 (4 de febrero de 2020): 706–17. http://dx.doi.org/10.1021/acschembio.9b00945.
Texto completoGhosh, Avick Kumar, Indranil Samanta, Anushree Mondal y Wenshe Ray Liu. "Covalent Inhibition in Drug Discovery". ChemMedChem 14, n.º 9 (26 de marzo de 2019): 889–906. http://dx.doi.org/10.1002/cmdc.201900107.
Texto completoRao, AK y MA Kowalska. "ADP-induced platelet shape change and mobilization of cytoplasmic ionized calcium are mediated by distinct binding sites on platelets: 5'- p-fluorosulfonylbenzoyladenosine is a weak platelet agonist". Blood 70, n.º 3 (1 de septiembre de 1987): 751–56. http://dx.doi.org/10.1182/blood.v70.3.751.751.
Texto completoRao, AK y MA Kowalska. "ADP-induced platelet shape change and mobilization of cytoplasmic ionized calcium are mediated by distinct binding sites on platelets: 5'- p-fluorosulfonylbenzoyladenosine is a weak platelet agonist". Blood 70, n.º 3 (1 de septiembre de 1987): 751–56. http://dx.doi.org/10.1182/blood.v70.3.751.bloodjournal703751.
Texto completoBjij, Imane, Fisayo A. Olotu, Clement Agoni, Emmanuel Adeniji, Shama Khan, Ahmed El Rashedy, Driss Cherqaoui y Mahmoud E. S. Soliman. "Covalent Inhibition in Drug Discovery: Filling the Void in Literature". Current Topics in Medicinal Chemistry 18, n.º 13 (4 de octubre de 2018): 1135–45. http://dx.doi.org/10.2174/1568026618666180731161438.
Texto completoStrelow, John M. "A Perspective on the Kinetics of Covalent and Irreversible Inhibition". SLAS DISCOVERY: Advancing the Science of Drug Discovery 22, n.º 1 (5 de octubre de 2016): 3–20. http://dx.doi.org/10.1177/1087057116671509.
Texto completoKilbourn, R. y G. Lopez-Berestein. "Protease inhibitors block the macrophage-mediated inhibition of tumor cell mitochondrial respiration." Journal of Immunology 144, n.º 3 (1 de febrero de 1990): 1042–45. http://dx.doi.org/10.4049/jimmunol.144.3.1042.
Texto completoColman, RW, WR Figures, LM Scearce, AM Strimpler, FX Zhou y AK Rao. "Inhibition of collagen-induced platelet activation by 5'-p- fluorosulfonylbenzoyl adenosine: evidence for an adenosine diphosphate requirement and synergistic influence of prostaglandin endoperoxides". Blood 68, n.º 2 (1 de agosto de 1986): 565–70. http://dx.doi.org/10.1182/blood.v68.2.565.565.
Texto completoColman, RW, WR Figures, LM Scearce, AM Strimpler, FX Zhou y AK Rao. "Inhibition of collagen-induced platelet activation by 5'-p- fluorosulfonylbenzoyl adenosine: evidence for an adenosine diphosphate requirement and synergistic influence of prostaglandin endoperoxides". Blood 68, n.º 2 (1 de agosto de 1986): 565–70. http://dx.doi.org/10.1182/blood.v68.2.565.bloodjournal682565.
Texto completoTian, Yafeng, Mi Zhang, Panpan Heng, Hua Hou y Baoshan Wang. "Computational Investigations on Reaction Mechanisms of the Covalent Inhibitors Ponatinib and Analogs Targeting the Extracellular Signal-Regulated Kinases". International Journal of Molecular Sciences 24, n.º 20 (16 de octubre de 2023): 15223. http://dx.doi.org/10.3390/ijms242015223.
Texto completoZhou, X. Edward, Kelly Suino-Powell, Chad R. Schultz, Bilal Aleiwi, Joseph S. Brunzelle, Jared Lamp, Irving E. Vega, Edmund Ellsworth, André S. Bachmann y Karsten Melcher. "Structural basis of binding and inhibition of ornithine decarboxylase by 1-amino-oxy-3-aminopropane". Biochemical Journal 478, n.º 23 (6 de diciembre de 2021): 4137–49. http://dx.doi.org/10.1042/bcj20210647.
Texto completoKinoshita, T., A. W. Dodds, S. K. A. Law y K. Inoue. "The low C5 convertase activity of the C4A6 allotype of human complement component C4". Biochemical Journal 261, n.º 3 (1 de agosto de 1989): 743–48. http://dx.doi.org/10.1042/bj2610743.
Texto completoStevic, Ivan, Howard H. W. Chan, Ankush Chander, Leslie R. Berry y Anthony K. C. Chan. "Covalently linking heparin to antithrombin enhances prothrombinase inhibition on activated platelets". Thrombosis and Haemostasis 109, n.º 06 (2013): 1016–24. http://dx.doi.org/10.1160/th12-10-0766.
Texto completoSim, E., A. W. Dodds y A. Goldin. "Inhibition of the covalent binding reaction of complement component C4 by penicillamine, an anti-rheumatic agent". Biochemical Journal 259, n.º 2 (15 de abril de 1989): 415–19. http://dx.doi.org/10.1042/bj2590415.
Texto completoLu, Jia-Hui, Zhen Li, Jia-Hui Chen, Shu-Liang Li, Jie-Hao He, Song Gu, Bo-Wen Liu, Li Chen y Yu-Zhong Wang. "Adaptable Phosphate Networks towards Robust, Reprocessable, Weldable, and Alertable-Yet-Extinguishable Epoxy Vitrimer". Research 2022 (6 de octubre de 2022): 1–12. http://dx.doi.org/10.34133/2022/9846940.
Texto completoRuddraraju, Kasi Viswanatharaju y Zhong-Yin Zhang. "Covalent inhibition of protein tyrosine phosphatases". Molecular BioSystems 13, n.º 7 (2017): 1257–79. http://dx.doi.org/10.1039/c7mb00151g.
Texto completoZhao, Yuguang, Fredrik Svensson, David Steadman, Sarah Frew, Amy Monaghan, Magda Bictash, Tiago Moreira et al. "Structural Insights into Notum Covalent Inhibition". Journal of Medicinal Chemistry 64, n.º 15 (22 de julio de 2021): 11354–63. http://dx.doi.org/10.1021/acs.jmedchem.1c00701.
Texto completoWestover, Kenneth D., Pasi A. Jänne y Nathanael S. Gray. "Progress on Covalent Inhibition of KRASG12C". Cancer Discovery 6, n.º 3 (marzo de 2016): 233–34. http://dx.doi.org/10.1158/2159-8290.cd-16-0092.
Texto completoJacobs, Amy. "Covalent Inhibition of HIV Membrane Fusion". Biophysical Journal 96, n.º 3 (febrero de 2009): 359a. http://dx.doi.org/10.1016/j.bpj.2008.12.1814.
Texto completoHuang, Huang, Christina A. Howard, Sergei Zari, Hyo Je Cho, Shirish Shukla, Hao Li, Juliano Ndoj et al. "Covalent inhibition of NSD1 histone methyltransferase". Nature Chemical Biology 16, n.º 12 (31 de agosto de 2020): 1403–10. http://dx.doi.org/10.1038/s41589-020-0626-6.
Texto completoAmara, Neri, Roi Mashiach, Dotan Amar, Pnina Krief, Stéphane A. H. Spieser, Matthew J. Bottomley, Amir Aharoni y Michael M. Meijler. "Covalent Inhibition of Bacterial Quorum Sensing". Journal of the American Chemical Society 131, n.º 30 (5 de agosto de 2009): 10610–19. http://dx.doi.org/10.1021/ja903292v.
Texto completoKentner, Taryn A., Leslie R. Berry y Anthony K. C. Chan. "Inhibition of Factor Xa in Prothrombinase Is Enhanced by Covalent Linkage of Antithrombin to Heparin." Blood 104, n.º 11 (16 de noviembre de 2004): 1051. http://dx.doi.org/10.1182/blood.v104.11.1051.1051.
Texto completoNAGUMO, Yoko, Hideaki KAKEYA, Mitsuru SHOJI, Yujiro HAYASHI, Naoshi DOHMAE y Hiroyuki OSADA. "Epolactaene binds human Hsp60 Cys442 resulting in the inhibition of chaperone activity". Biochemical Journal 387, n.º 3 (26 de abril de 2005): 835–40. http://dx.doi.org/10.1042/bj20041355.
Texto completoJebaraj, Billy Michael Chelliah, Annika Müller, Rashmi Priyadharshini Dheenadayalan, Sascha Endres, Philipp M. Roessner, Felix Seyfried, Claudia Walliser et al. "Evaluation of vecabrutinib as a model for noncovalent BTK/ITK inhibition for treatment of chronic lymphocytic leukemia". Blood 139, n.º 6 (10 de febrero de 2022): 859–75. http://dx.doi.org/10.1182/blood.2021011516.
Texto completoWágner, Gábor, Tamara A. M. Mocking, Albert J. Kooistra, Inna Slynko, Péter Ábrányi-Balogh, György M. Keserű, Maikel Wijtmans, Henry F. Vischer, Iwan J. P. de Esch y Rob Leurs. "Covalent Inhibition of the Histamine H3 Receptor". Molecules 24, n.º 24 (11 de diciembre de 2019): 4541. http://dx.doi.org/10.3390/molecules24244541.
Texto completoThøgersen, I. B., G. Salvesen, F. H. Brucato, S. V. Pizzo y J. J. Enghild. "Purification and characterization of an α-macroglobulin proteinase inhibitor from the mollusc Octopus vulgaris". Biochemical Journal 285, n.º 2 (15 de julio de 1992): 521–27. http://dx.doi.org/10.1042/bj2850521.
Texto completoShatan, Anastasiia B., Vitalii Patsula, Hana Macková, Andrii Mahun, Renáta Lehotská, Elena Piecková y Daniel Horák. "Silver-Sulfamethazine-Conjugated β-Cyclodextrin/Dextran-Coated Magnetic Nanoparticles for Pathogen Inhibition". Nanomaterials 14, n.º 4 (17 de febrero de 2024): 371. http://dx.doi.org/10.3390/nano14040371.
Texto completoLee, Jesang y Seung Bum Park. "Extended Applications of Small-Molecule Covalent Inhibitors toward Novel Therapeutic Targets". Pharmaceuticals 15, n.º 12 (27 de noviembre de 2022): 1478. http://dx.doi.org/10.3390/ph15121478.
Texto completoWalderveen, Maria Christina Van, Leslie Roy Berry, Helen Mary Atkinson y Anthony Kam Chuen Chan. "Covalent antithrombin-heparin effect on thrombin-thrombomodulin and activated protein C reaction with factor V/Va". Thrombosis and Haemostasis 103, n.º 05 (2010): 910–19. http://dx.doi.org/10.1160/th09-07-0473.
Texto completoAllgardsson, Anders, Lotta Berg, Christine Akfur, Andreas Hörnberg, Franz Worek, Anna Linusson y Fredrik J. Ekström. "Structure of a prereaction complex between the nerve agent sarin, its biological target acetylcholinesterase, and the antidote HI-6". Proceedings of the National Academy of Sciences 113, n.º 20 (2 de mayo de 2016): 5514–19. http://dx.doi.org/10.1073/pnas.1523362113.
Texto completoLee, Chang-Uk y Tom N. Grossmann. "Reversible Covalent Inhibition of a Protein Target". Angewandte Chemie International Edition 51, n.º 35 (13 de julio de 2012): 8699–700. http://dx.doi.org/10.1002/anie.201203341.
Texto completoAhmed, Vanessa F., Nunzio Bottini y Amy M. Barrios. "Covalent Inhibition of the Lymphoid Tyrosine Phosphatase". ChemMedChem 9, n.º 2 (8 de enero de 2014): 296–99. http://dx.doi.org/10.1002/cmdc.201300404.
Texto completoStevic, Ivan, Howard H. W. Chan, Ankush Chander, Leslie R. Berry y Anthony K. C. Chan. "Inhibition of Platelet-Prothrombianse by a Covalent Antithrombin-Heparin Complex." Blood 120, n.º 21 (16 de noviembre de 2012): 2212. http://dx.doi.org/10.1182/blood.v120.21.2212.2212.
Texto completoZhou, Yuxin, Ji Tao, Dingshuainan Jin, Shiping Zhang, Yan He y Longlong Niu. "The Inhibition Effect and Mechnism of a Thiadiazole Derivative on Q235 Carbon Steel in 1 M HCl Solution". Applied Sciences 13, n.º 4 (6 de febrero de 2023): 2103. http://dx.doi.org/10.3390/app13042103.
Texto completoBuneeva, O. A., L. N. Aksenova y A. E. Medvedev. "A Simple Approach for Pilot Analysis of Time-dependent Enzyme Inhibition: Discrimination Between Mechanism-based Inactivation and Tight Binding Inhibitor Behavior". Biomedical Chemistry: Research and Methods 3, n.º 1 (2020): e00115. http://dx.doi.org/10.18097/bmcrm00115.
Texto completoWang, Qian, Guofeng Chen, Jian He, Jiameng Li, Muya Xiong, Haixia Su, Minjun Li, Hangchen Hu y Yechun Xu. "Structure-Based Design of Potent Peptidomimetic Inhibitors Covalently Targeting SARS-CoV-2 Papain-like Protease". International Journal of Molecular Sciences 24, n.º 10 (11 de mayo de 2023): 8633. http://dx.doi.org/10.3390/ijms24108633.
Texto completoAbdeldayem, Ayah, Yasir S. Raouf, Stefan N. Constantinescu, Richard Moriggl y Patrick T. Gunning. "Advances in covalent kinase inhibitors". Chemical Society Reviews 49, n.º 9 (2020): 2617–87. http://dx.doi.org/10.1039/c9cs00720b.
Texto completo